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bstract
e have analysed the growth and differentiation of mesenchymal stromal cells (MSC) from bone marrow, and of adipose derived stem cells
ASC) from murine abdominal fat tissue, of green fluorescent protein (GFP) transgenic animals grown directly on two types of hydroxyapatite
eramic bone substitutes. BONITmatrix® and NanoBone® have specific mechanical and physiochemical properties such as porosity and an
nner surface that influence cellular growth. Both MSC and ASC were separately seeded on 200 mg of each biomaterial and cultured for 3
eeks under osteogenic differentiation conditions. The degree of mineralisation was assessed by alizarin red dye and the specific alkaline
hosphatase activity of the differentiated cells. The morphology of the cells was examined by scanning electron microscopy and confocal
icroscopy. The osteoblastic phenotype of the cells was confirmed by analysing the expression of bone-specific genes (Runx2, osteocalcin,
steopontin, and osteonectin) by semiquantitative reverse transcriptase polymerase chain reaction (PCR).
Comparison of BONITmatrix® and NanoBone® showed cell type-specific preferences in terms of osteogenic differentiation. MSC-derived
steoblast-like cells spread optimally on the surface of NanoBone® but not BONITmatrix® granules. In contrast BONITmatrix® granules
onditioned the growth of osteoblast-like cells derived from ASC. The osteoblastic phenotype of the cultured cells on all matrices was
onfirmed by specific gene expression.
Our results show that the in vitro growth and osteogenic differentiation of murine MSC or ASC of GFP transgenic mice are distinctly
nfluenced by the ceramic substratum. While NanoBone® granules support the proliferation and differentiation of murine MSC isolated from
one marrow, the growth of murine ASC is supported by BONITmatrix® granules. NanoBone® is therefore recommended for use as scaffold
n tissue engineering that requires MSC, whereas ASC can be combined with BONITmatrix® for in vitro bone engineering. 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. 
eywords: NanoBone®; BONITmatrix®; Mesenchymal stromal cells; Adipose-derived stem cells; Osteoblast-like cells; Bone tissue engineering; Green
uorescent protein; Hydroxyapatite
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esenchymal stromal cells (MSC) and adipose-derived stem
ells (ASC) are becoming more and more important in oral
nd maxillofacial tissue engineering because of their abil-
ty to differentiate into multiple types of cell. They can be
solated from different sources. Friedenstein et al. described
one marrow as a source for MSC in 1968 for humans and for
ice 8 years later.1,2 However, because of ethical concerns
nd the high donor site morbidity during the harvesting of
one marrow stem cells, other sources have been taken into
onsideration, such as the pancreas or adipose tissue.3
ASC have been isolated and characterised by many
roups.4–7 The advantage of adipose tissue is that it is easy to
arvest and huge amounts of tissue are available for isolation
f stromal cells. Like other mesenchymal cells, ASC have
he ability to differentiate into chondrocytes, osteoblasts, or
dipocytes.6
In the present study we have compared the in vitro use of
SC and ASC for osteogenic differentiation on a collagen
atrix (control) and two types of hydroxyapatite ceram-
cs with osteoconductive properties: BONITmatrix® and
anoBone® granules.
aterials  and  methods
solation of  cells
SC were isolated from the bone marrow of female GFP
ransgenic C57/Bl6 mice that had been harvested from femurs
nd tibias and processed as described by Phinney et al.8
dherent MSC were maintained in MesenCult Medium
Stemcell Technologies) according to the manufacturer’s
nstructions. ASC were isolated from subcutaneous (abdomi-
al) fatty tissue of GFP transgenic C57/Bl6-mice as described
y Bunnell et al.9
eeding  of  biomaterial
he biomaterials NanoBone® (Artoss GmbH) and
ONITmatrix® (DOT GmbH) were rehydrated in modified
agle’s medium (MEM) alpha (PAA Cell Culture Company)
2 h before seeding. Afterwards the biomaterial was covered
ith human platelet-rich plasma (hPRP) for 30 min to mimic
he clinical use of paste-like biomaterial mixed with blood.
fter it had been washed twice with medium, 200 mg of the
iomaterial was seeded with cells. The Parasorb collagen
one (Resorba) (control) was cut into discs 2 mm thick, and
he experiment proceeded in parallel to the biomaterials. Two
ours after seeding, the wells were filled with differentiation
edium.
F
s
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ifferentiation
or the osteogenic differentiation, cells were seeded into a 24-
ell plate with a density of 3.7 ×  104 cells/well using stromal
edium (MEM alpha modification and 20% foetal bovine
erum (FBS) gold (both PAA Cell Culture Company)). After
 days, when they reached a confluence of about 65%, differ-
ntiation medium (MEM alpha modification, 20% FBS gold,
.1 mmol l-ascorbic acid (Sigma), 10 nm dexamethasone
Sigma), 10 mmol -glycerophosphate (Fluka)) was added.
he medium was changed twice a week and osteogenic dif-
erentiation was seen after 3 weeks.
istochemistry
he alkaline phosphatase assay (LAP-kit, No. 86,
igma–Aldrich) was done according to the manufacturers
nstructions, and alizarin red staining with Alizarin red S
Roth, C.I. 58005).
olecular biology
NA was isolated from both biomaterials and the colla-
en control using the RNeasy Mini Kit (Qiagen) and the
everse transcription using Omniscript RT Kit (Qiagen). Gene
xpression of bone-specific genes Runx2, osteocalcin, osteo-
ontin, and osteonectin was analysed semiquantitatively
y reverse transcriptase polymerase chain reaction (PCR)
sing glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
s reference. Scale intensity values were calculated using
mageJ (NIH, USA). Data from the 3 independent experi-
ental sets are given as mean (SD). Significant differences
ere calculated by 3-way ANOVA followed by a Tukey post
oc test using Sigma plot 12.3 (Jandel Scientific, Erkrath,
ermany). Probabilities of less than 0.05 were accepted as
ignificant. A significant interaction was calculated between
ell type and scaffold type regarding gene expression of
unx2 (p  = <0.001).
The following primer pairs were used: murine osteonectin:
or 5′-GTC TCA CTG GCT GTG TTG GA-3′, rev 5′-AAG
CT TGC CAT GTG GGT TC-3′; murine osteopontin: for 5′-
GA TGA TGA TGA CGA TGG AG-3′, rev 5′-GAG GTC
TC ATC TGT GGC AT-3′; murine osteocalcin: for 5′-CCT
TT GAA AGA GTG GGC TG-3′, rev 5′-CCT CGG GAG
CA AAC AAC AT-3′; murine runx2 (Runx2): for 5′-TGT
CT CTG ATC GCC TCA GTG-3′, rev 5′-CCT GGG ATC
GT AAT CTG ACT CT-3′; GAPDH for 5′-AGG TGG TGA
GC AGG CAT C-3′, rev 5′-GTG GGT GCA GCG AAC
TT ATT G-3′.
onfocal microscopyor the analyses of cellular growth and differentiation on the
urface of the scaffold we used a confocal microscope Zeiss
10 (Carl Zeiss, Jena, Germany) with corresponding camera
al and Maxillofacial Surgery 52 (2014) 409–414 411
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granules and spanning micropores and macropores. On this
type of surface, mature osteoblastic cells proliferated highly,
forming a thick mantle around the granules (Fig. 2).G. Wittenburg et al. / British Journal of Or
ystem. GFP transgenic cells were detected by an Argon laser
t 477 nm (supplemental data).
canning  electron  microscopy
amples were incubated in 4% paraformaldehyde/25% glu-
araldehyde including 0.2 M Hepes (PAA Cell Systems,
H 7.4) for 24 h fixation at 4 ◦C, washed for 10 min in
.2 M Hepes, incubated for 45 min with ammonium chloride
0 mmol including 0.2 M Hepes and washed again twice for
0 min in 0.2 M Hepes. Samples were dehydrated in an alco-
ol gradient 30 min for each step in 50%, 70%, 80%, 90%, and
6% ethanol, and 3 times in 100% ethanol. They were dried
o a critical point in a CPD 030 (PROVAC AG, Balzers, FL).
mmediately afterwards dried samples of biomaterial were
laced in a desiccator under vacuum until gold sputtering
ith a Cool-Sputter-Coater S150B (Edwards High Vacuum
nternational, Crawley, West Sussex, UK). We used a scan-
ing electron microscope XL 30 ESEM (Philips, Eindhoven,
L) to analyse the samples (n  = 9).
esults
steogenic  differentiation  of  MSC  and  ASC  in
onolayer controls
o test whether GFP transgenic cells have the same capac-
ty to differentiate as is described for their non-transgenic
ounterparts, GFP transgenic MSC and ASC were induced to
evelop osteoblast-like phenotypes. After 3 weeks of differ-
ntiation MSC and ASC showed a highly specific enzymatic
ctivity of the alkaline phosphatase. Mineralisation occurred
n the culture plate as shown by alizarin red staining. Both
esults confirm the capability of the GFP transgenic cell types
o differentiate into osteoblast-like cells.
ene expression  of  bone-speciﬁc  genes
ifferentiated cells were analysed by semi-quantitative RT
CR for their expression of bone-specific genes runx2
Runx2), osteocalcin, osteonectin, and osteopontin using
APDH as a reference gene. MSC-derived osteoblast-like
ells cultured on BONITmatrix® expressed significantly less
unx2 [0.72 (SD 0.1)] than those grown on NanoBone®
1.0 (0.1); p  < 0.001) or those grown on the collagen control
arasorb (1.0 (0.1); p  < 0.001) normalised to GAPDH. The
xpression of osteocalcin, osteonectin, or osteopontin did not
iffer among the colonised biomaterials.
In contrast, ASC-derived osteoblaset-like cells grown on
anoBone® showed significantly less Runx2 expression
0.72 (0.1)) than those grown on BONITmatrix® (1.0 (0.1);
 < 0.001) or grown on the collagen control Parasorb (1.0
0.1); p  < 0.001). Again, the expression of osteocalcin,
steonectin, and osteopontin did not differ among the
olonised biomaterials. These results suggest a material
F
cig. 1. On BONITmatrix®, mesenchymal stromal cell-derived osteoblast-
ike cells covered the surface of the ceramic material (scale bar 200 m).
reference to MSC-derived osteoblast-like cells for
anoBone®, and to ASC-derived osteoblast-like cells
or BONITmatrix® as substratum during osteogenic
ifferentiation in vitro.
ell distribution  conﬁrmed  by  scanning  electron
icroscopy
fter osteogenic differentiation, MSC or ASC-derived cells
ere further investigated for specific growth in the substra-
um. On BONITmatrix®, a minor part of the MSC-derived
steoblast-like cells were fully differentiated. The cells had a
pindle-shaped phenotype, meaning that they had not grown
o mature osteoblasts but remained in a preosteoblastic state.
he cells covered the granular surface mostly in a monolayer
Fig. 1).
On NanoBone®, differentiated MSC-derived osteoblast-
ike cells grew densely packed, and filled the depth of theig. 2. On NanoBone®, mesenchymal stromal cell-derived osteoblast-like
ells induced sail-shaped cell-units (scale bar 800 m).
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tig. 3. Granule covering cell units of adipose-derived stem cells-derived
steoblast-like cells were found on BONITmatrix® (scale bar 200 m).
Some samples showed the shedding of tissue-like struc-
ures from the substratum. In contrast, osteoblast-like cells of
SC progeny differentiated on BONITmatrix® into a clearly
steoblastic phenotype, forming tissue-like monolayers that
overed the individual granules. Granule spanning cell-units
ere also seen on BONITmatrix®, when grown with differ-
ntiated ASC-derived osteoblast-like cells (Fig. 3). The same
ells grown on NanoBone® granules covered the surface less
ffectively (Fig. 4).
Osteoblast-like cells differentiated from either type were
qually distributed in the inner layer of the collagen material
arasorb (Figs. 5 and 6), which served as the control.
iscussion
arge bony defects still pose a big challenge to current ther-
peutic concepts of oral and maxillofacial surgery. Synthetic
aterials for bony replacement are mostly used with com-
lementary osteosynthesis. However, vascularisation and
ellular ossification of the material are essential to achieve
ig. 4. On NanoBone® adipose-derived osteoblast-like cells covered the
urface partly (scale bar 200 m).
t
N
s
F
tig. 5. All mesenchymal stromal cells-derived osteoblast-like cells migrated
nto the collagen network of the control material Parasorb (scale bar 200 m).
obust bony connections. That was precisely the reason why
e aimed at the complete fusion of hydroxyapatite materials
ith mesenchymal stromal cells. We wanted to know whether
ultipotent cells derived from either bone marrow or fat tis-
ue may be more prone to accelerate bony regeneration on a
ertain type of scaffold.
We therefore analysed different commercially available
nd clinically approved biomaterials for their potential appli-
ation for bone formation using murine stem cells, and tested
he impact of BONITmatrix®, NanoBone® and Parasorb on
he osteogenic differentiation of ASC and MSC in vitro.
Despite the low proportion of both MSC and ASC in the
ell culture there were no limitations in the differentiation
ehaviour of cells in terms of the development of osteoblasts,
s was proved by the differentiation of adherent stromal cells
hat stained for alkaline phosphatase activity and mineralisa-
ion by alizarin red.
While the osteogenic differentiation was successful in
he presence of differentiation media on BONITmatrix®,
anoBone® and the collagen control (underlined by the bone
pecific gene expression) none of the matrices could by itself
ig. 6. Differentiated adipose-derived stem cells are located inside the con-
rol material Parasorb (scale bar 200 m).
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romote osteogenic differentiation within 3 weeks in cul-
ure. They are therefore not characterised as osteoinductive
or in vitro experiments.
The Parasorb collagen, which is currently used as a
aemostyptic device for therapeutic haemostasis after tooth
xtraction, served as the control biomaterial. However, this
aterial is not suitable for the production of solid bone tissue
ngineering constructs, as it consists only of elastic collagen
bres.
ONITmatrix®
he granular BONITmatrix® is a material for bony regen-
ration that is synthesised by a sol–gel process at low
emperature without sintering. It is structured as a compos-
te material that consists of 2 calcium phosphate components
60% hydroxyapatite/40% -tricalcium phosphate, w/w) and
ontains a silica portion of 13%. The granules have a high
orosity realised by an interconnective micropore and macro-
ore system, with a mean pore size between 90 and 400 nm
n diameter. It is mainly used for augmentation of defects in
he maxillofacial region.
BONITmatrix® was also successfully tested to fill cra-
ial defects, and as a coating for titanium implants.10,11 The
valuation of the BONITmatrix® samples showed that the
ntire surface of the granules was overgrown with cells after
 weeks of cultivation. The high cellular affinity to the mate-
ial might be explained by its specific surface charges. Zeta
otential measurements of BONITmatrix® at neutral pH pre-
ented distinct negative charges of −34.1 mV (Teller M, et al.,
urface properties of calcium phosphate silica composite
aterial and their relation to biocompatibility. Paper pre-
ented at 20th European Conference on Biomaterials, Nantes,
006). Further measurements of the charge density of its sin-
le components showed that the main part of the negative
harge in the composite is caused by embedded hydroxyap-
tite particles. Proteins and cellular adhesion molecules can
herefore easily cover the composite surface.
In vitro cell attachment, cell expansion, and differenti-
tion on biomaterials are indispensable for further in vivo
se of cell material constructs. After 3 weeks of osteogenic
timulation, less mature osteoblasts derived from MSC than
ere derived from ASC are found on the material. This
s reflected by the difference in the mean (SD) values of
unx2 gene expression (MSC (0.72 (0.1)) ≤  ASC (1.0 (0.19))
etween MSC and ASC both cultured on BONITmatrix®,
hich was significant (p  < 0.001). Osteonectin and osteo-
ontin are strongly expressed in both settings, which could
e attributed to the high proportion of undesired fibroblasts
n both cell cultures. As well as the influence of composi-
ion, surface topography, or porosity of the material, it has
een shown that the variation of surface charge by manipula-
ion with electrically polarised hydroxyapatite can massively
nfluence cell proliferation (Teller M, et al. Surface proper-
ies of calcium phosphate silica composite material and their
N
N
a
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elation to biocompatibility. Paper presented at 20th Euro-
ean Conference on Biomaterials, Nantes, 2006).
anoBone®
ith the colonisation of MSC on NanoBone® granules we
btained the best results for growth and proliferation of
steoblasts. NanoBone® is a highly porous (61%) biomaterial
ith interconnecting pores down to the nanometer size range
10–20 nm), which consists of nanocrystalline hydroxyap-
tite embedded in a matrix of silica gel (about 76%/24%,
/w). It was originally designed to replenish bone defects in
he oral and maxillofacial region.12 During the remodelling
f bone, autologous bone is completely substituted for it.13
ecause of its osteoconductivity, NanoBone® serves two cru-
ial properties in vivo. First, it is a guide for the formation of
ew bone. Secondly, because of its negative surface charge it
s rapidly covered with proteins and growth factors, so pro-
oting the ingrowth of blood vessels, which is crucial for the
stablishment of solid autologous bone.14 The use of addi-
ional autologous stem cells was initially thought to accelerate
ony regeneration, particularly to treat large bony defects.
hile Henkel et al. found no significant improvement in bony
ormation by the use of osteoblast seeded NanoBone® gran-
les, Dong et al. stated the opposite.15,16 They postulated
hat the addition of osteoblasts was significantly better than
he empty NanoBone® control. Our own results support this
onclusion.
Tissue engineered bone grafts from NanoBone® and MSC
ssified almost completely under osteogenic culture condi-
ions. This was verified by the expression of the marker gene
unx2. The difference in the mean (SD) values of Runx2
ene expression between MSC and ASC both cultured on
anoBone® (ASC (0.72 (0.1)) ≤  MSC (1.0 (0.19)) is signif-
cant (p  < 0.001). While the expression of Runx2 indicates
he development of MSC-derived preosteoblasts, the stable
xpression of osteocalcin underlines this effect of a surplus
f preosteoblasts compared with mature osteoblasts on the
anoBone® samples.17
On cross-sectional images of the NanoBone® granules
e found that the MSC-derived cells not only spanned the
acropores of the granules, but also entered the depth of the
articles (supplemental data). Obviously NanoBone® gran-
les are capable of complying with all the demands of stem
ells from murine bone marrow and simultaneously support
he growth and vitality of mature osteoblasts. Presumably
his osteoconductive effect relies on the properties of the
anocrystalline surface, which distinguishes the NanoBone®
rom the other substrates. Based on the calculations of Teller
t al. (Surface properties of calcium phosphate silica com-
osite material and their relation to biocompatibility. Paper
resented at 20th European Conference on Biomaterials,
antes, 2006) this effect might be led by the surface charge.
anoBone® has more hydroxyapatite in the composite, with
 proportion of about 16% more than BONITmatrix®. This
hould influence the surface charge of NanoBone®, because
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e know that the negative charge in the composite is caused
ainly by the embedded hydroxyapatite particles. The higher
egative surface charge could be the reason why MSC prefer
o grow on NanoBone® granules.
Generally, bone tissue engineered constructs with stromal
ells can induce bone formation. Before its use in vivo it
hould be critically validated, to find out if cells and bioma-
erial fit together optimally. It has to be decided, depending
n the most suitable biomaterial chosen for regeneration,
hether MSC or ASC will find optimal growth conditions
n the composition, surface topography, porosity, or surface
harge of the material.
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